Characterization of novel CASQ1 variants in two families with unusual phenotypic features

dc.contributor.authorLaarne, Milla
dc.contributor.authorJokela, Manu
dc.contributor.authorZhao, Fang
dc.contributor.authorHuovinen, Sanna
dc.contributor.authorKornblum, Cornelia
dc.contributor.authorReimann, Jens
dc.contributor.authorJohari, Mridul
dc.contributor.authorVihola, Anna
dc.contributor.authorSarparanta, Jaakko
dc.contributor.authorUdd, Bjarne
dc.contributor.authorHackman, Peter
dc.contributor.authorLehtokari, Vilma-Lotta
dc.contributor.authorPelin, Katarina
dc.contributor.organizationfi=kliiniset neurotieteet|en=Clinical Neurosciences|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code2607314
dc.converis.publication-id505669469
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/505669469
dc.date.accessioned2026-01-21T12:44:39Z
dc.date.available2026-01-21T12:44:39Z
dc.description.abstract<h3>Background</h3><p>Variants in <em>CASQ1</em>, encoding a calcium-binding protein in the fast-twitch fibers of skeletal muscle, cause sarcoplasmic reticulum aberrations such as large vacuoles with CASQ1 inclusions or, less commonly, tubular aggregates. To date, seven pathogenic variants have been described, all dominant missense variants. The typical symptoms of the disease include muscle weakness, cramps, myalgia, and fatigue.</p><h3>Methods</h3><p>We used genome and exome sequencing to identify the disease-causing variants in two families with dominant myopathy. The candidate variants were further characterized by cell-transfection studies and western blotting.</p><h3>Results</h3><p>In Family 1, three patients presented with exercise intolerance, cramps, and myalgia. Additionally, the proband had muscle weakness and her muscle biopsy showed nemaline bodies. In electron microscopy, there were morphological changes in the triads and the SR-feet in all patients. A variant in <em>CASQ1</em>, p.(Glu89Lys), was found in all patients, whereas the proband had also two compound heterozygous variants in <em>NEB</em>. In Family 2, three patients presented with progressive muscle weakness. The proband’s muscle biopsy showed marked atrophy. The frameshift variant p.(Gly383Alafs*39) in <em>CASQ1</em> was found in all three patients. In silico analysis indicated that the variant results in protein extension, which was confirmed by western blotting of patient muscle. Cell-transfection studies showed that the variant protein forms aggregates.</p><h3>Conclusion</h3><p>This study expands the spectrum of pathogenic <em>CASQ1</em> variants. The morphological changes in the SR-feet indicate a novel pathogenetic mechanism.</p>
dc.identifier.eissn1432-1459
dc.identifier.jour-issn0340-5354
dc.identifier.olddbid212922
dc.identifier.oldhandle10024/195940
dc.identifier.urihttps://www.utupub.fi/handle/11111/54064
dc.identifier.urlhttps://doi.org/10.1007/s00415-025-13512-3
dc.identifier.urnURN:NBN:fi-fe202601217268
dc.language.isoen
dc.okm.affiliatedauthorJokela, Manu
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3112 Neurosciencesen_GB
dc.okm.discipline3124 Neurology and psychiatryen_GB
dc.okm.discipline3112 Neurotieteetfi_FI
dc.okm.discipline3124 Neurologia ja psykiatriafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSpringer Nature
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.relation.articlenumber789
dc.relation.doi10.1007/s00415-025-13512-3
dc.relation.ispartofjournalJournal of Neurology
dc.relation.issue12
dc.relation.volume272
dc.source.identifierhttps://www.utupub.fi/handle/10024/195940
dc.titleCharacterization of novel CASQ1 variants in two families with unusual phenotypic features
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s00415-025-13512-3.pdf
Size:
2.48 MB
Format:
Adobe Portable Document Format